secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIM ImmunoTech Inc. (AIM)
CIK:        0000946644
Form:       8-K
Filed at:   2024-01-25T23:59:59+00:00
Accession:  0001493152-24-003779
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AIM ImmunoTech furnishes supplemental data deck on pancreatic cancer Early Access Program
--------------------------------------------------------------------------------

- Deck titled 'Pancreatic Cancer Early Access Program Supplemental Data Q1 2024' furnished as Exhibit 99.1.
- Data posted on the 'Investors' section of the company's website.
- No specific clinical results or financial figures disclosed in the 8-K filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946644/000149315224003779/0001493152-24-003779-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946644/000149315224003779/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-003779

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer